DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

CTI Clinical Trial & Consulting Services (CTI), a global, privately held, full-service research organization, headquartered ...

Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer (“Biodexa” or “the Company”), ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC ("Biodexa" or "the Company"), (Nasdaq: BDRX), a clinical ...

Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...

Subsequent research has pointed to a value premium ... Those companies that successfully usher a treatment through the various phases of clinical testing and eventually bring it to market can ...

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...